California's newly enacted Assembly Bill 1965 will require licensed cannabis retailers to provide customers with laboratory testing documentation upon request starting January 1, 2027, a change that could significantly alter how patients evaluate the products they purchase. The law, signed on September 27, 2026, amends Sections 26070, 26100, and 26104 of the California Business and Professions Code and expands the authority of the California Department of Cannabis Control (DCC) to oversee cannabis product testing.
The implications for medical cannabis patients are substantial. Although AB 1965 does not change medical marijuana recommendation eligibility, its transparency provisions give patients direct access to Certificates of Analysis (COAs), the documents that record testing results for cannabinoid concentrations, pesticides, heavy metals, microbial impurities, and other regulated contaminants. Under the DCC's official cannabis testing guidance, licensed laboratories already examine products for these substances before they reach retail shelves, but until now patients have not had a guaranteed right to see the underlying reports.
The law also strengthens regulatory oversight by authorizing the DCC to obtain cannabis products offered for retail sale for independent, off-the-shelf laboratory testing. This provision, which includes retesting and laboratory procedure improvements, is designed to ensure consistency across testing facilities and build upon California's existing quality assurance framework. The DCC's cannabis laws and regulations provide further detail on the requirements governing licensed businesses.
For patients, the practical effect is that a COA can help them review cannabinoid concentrations and testing results for contaminants, though a laboratory report does not establish whether a product is medically appropriate for an individual. Medical Marijuana Card California, which announced the changes, emphasized the importance of distinguishing between medical cannabis recommendations, county-issued identification cards, and product testing regulations. According to the California Department of Public Health's official MMIC guidance, patients seeking a county-issued card must provide a physician's recommendation, proof of identity, and proof of residency, a separate process from the testing rules.
Patients preparing for the new requirements can take steps such as learning how COAs document testing results, verifying retailer licensing through the DCC's official license search, and keeping physician recommendations current. The requirements are intended to strengthen product testing oversight and transparency, not to alter medical eligibility or physician certification standards.
